Você procurou por: ανοσοτροποποιητικών (Grego - Inglês)

Contribuições humanas

A partir de tradutores profissionais, empresas, páginas da web e repositórios de traduções disponíveis gratuitamente

Adicionar uma tradução

Grego

Inglês

Informações

Grego

Διακοπή ανοσοτροποποιητικών 2

Inglês

discontinuation of immunomodulators2

Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:

Grego

Διακοπή Κορτικοστεροειδών ή Ανοσοτροποποιητικών και Σύγκλιση Συριγγίων

Inglês

discontinuation of corticosteroids or immunomodulators and fistula remission

Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:

Grego

Τα ποσοστά διακοπής των κορτικοστεροειδών ή των ανοσοτροποποιητικών παρουσιάζονται στον Πίνακα 22.

Inglês

rates of discontinuation of corticosteroids or immunomodulators are presented in table 22.

Última atualização: 2017-04-26
Frequência de uso: 3
Qualidade:

Grego

Οι παραπάνω επιδράσεις παρατηρήθηκαν ανεξάρτητα από την ταυτόχρονη χορήγηση ή μη χορήγηση ανοσοτροποποιητικών.

Inglês

these effects were seen whether or not immunomodulators were also concomitantly administered.

Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:

Grego

Επιτράπηκαν ταυτόχρονες σταθερές δόσεις από στόματος αμινοσαλικυλικών και/ή ανοσοτροποποιητικών παραγόντων.

Inglês

concomitant stable doses of oral aminosalicylates, and/or immunomodulatory agents were permitted.

Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:

Grego

Επιτρεπόταν η ταυτόχρονη χορήγηση σταθερών δόσεων από του στόματος κορτικοστεροειδών, ανοσοτροποποιητικών και αντιβιοτικών.

Inglês

concomitant stable doses of oral corticosteroids, immunomodulators, and antibiotics were permitted.

Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:

Grego

Ταυτόχρονες σταθερές δόσεις πόσιμων αμινοσαλικυλικών, κορτικοστεροειδών, και/ ή ανοσοτροποποιητικών παραγόντων επετράπησαν.

Inglês

concomitant stable doses of oral aminosalicylates, corticosteroids, and/ or immunomodulatory agents were permitted.

Última atualização: 2012-04-11
Frequência de uso: 3
Qualidade:

Grego

Επιτράπηκαν ταυτόχρονες σταθερές δόσεις από στόματος αμινοσαλικυλικών, κορτικοστεροειδών και/ή ανοσοτροποποιητικών παραγόντων.

Inglês

concomitant stable doses of oral aminosalicylates, corticosteroids, and/or immunomodulatory agents were permitted.

Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:

Grego

Επιτρεπόταν επίσης η ταυτόχρονη χορήγηση σταθερών δόσεων αμινοσαλικυλικών, κορτικοστεροειδών ή/και ανοσοτροποποιητικών από το στόμα.

Inglês

concomitant stable doses of oral aminosalicylates, corticosteroids and/or immunomodulators were permitted.

Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:

Grego

Η σύγχρονη χορήγηση ανοσοτροποποιητικών έχει συσχετισθεί με χαμηλότερη συχνότητα αντισωμάτων προς το infliximab και με μείωση της συχνότητας των αντιδράσεων έγχυσης.

Inglês

concomitant administration of immunomodulators has been associated with lower incidence of antibodies to infliximab and a reduction in the frequency of infusion reactions.

Última atualização: 2012-04-11
Frequência de uso: 3
Qualidade:

Grego

Ταυτόχρονες σταθερές δόσεις των από του στόματος χορηγούμενων αμινοσαλικυλικών, κορτικοστεροειδών, και/ή ανοσοτροποποιητικών παραγόντων επετράπησαν.

Inglês

concomitant stable doses of oral aminosalicylates, corticosteroids, and/or immunomodulatory agents were permitted.

Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:

Grego

Η ταυτόχρονη χορήγηση ανοσοτροποποιητικών έχει συσχετισθεί με χαμηλότερη επίπτωση των αντισωμάτων προς το infliximab και με μείωση της συχνότητας των αντιδράσεων έγχυσης.

Inglês

concomitant administration of immunomodulators has been associated with lower incidence of antibodies to infliximab and a reduction in the frequency of infusion reactions.

Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:

Grego

56 δόσεων αμινοσαλικυλικών, κορτικοστεροειδών και/ ή ανοσοτροποποιητικών παραγόντων επιτράπηκαν και το 79% των ασθενών συνέχισαν να λαμβάνουν τουλάχιστον μία από τις παραπάνω αγωγές.

Inglês

concomitant stable doses of aminosalicylates, corticosteroids, and/ or immunomodulatory agents were permitted and 79% of patients continued to receive at least one of these medications.

Última atualização: 2012-04-11
Frequência de uso: 4
Qualidade:

Grego

Ταυτόχρονη σταθερή χορήγηση δόσεων αμινοσαλικυλικών, κορτικοστεροειδών και/ή ανοσοτροποποιητικών παραγόντων επετράπησαν και το 79% των ασθενών συνέχισαν να λαμβάνουν τουλάχιστον μία από τις παραπάνω αγωγές.

Inglês

concomitant stable doses of aminosalicylates, corticosteroids, and/or immunomodulatory agents were permitted and 79% of patients continued to receive at least one of these medications.

Última atualização: 2008-03-04
Frequência de uso: 4
Qualidade:

Aviso: esta concordância pode estar incorreta.
Exclua-a, se este for o caso.

Grego

Σε ασθενείς με ρευματοειδή αρθρίτιδα, ψωριασική αρθρίτιδα και νόσο του crohn, υπάρχουν ενδείξεις ότι η σύγχρονη χρήση μεθοτρεξάτης και άλλων ανοσοτροποποιητικών μειώνει το σχηματισμό αντισωμάτων κατά του infliximab και αυξάνει τις συγκεντρώσεις πλάσματος του infliximab.

Inglês

in rheumatoid arthritis, psoriatic arthritis and crohn's disease patients, there are indications that concomitant use of methotrexate and other immunomodulators reduces the formation of antibodies against infliximab and increases the plasma concentrations of infliximab.

Última atualização: 2012-04-11
Frequência de uso: 2
Qualidade:

Grego

Ταυτόχρονη σταθερή χορήγηση δόσεων αμινοσαλικυλικών, κορτικοστεροειδών και/ ή ανοσοτροποποιητικών παραγόντων επιτράπηκαν και το 79% των ασθενών συνέχισαν να λαμβάνουν τουλάχιστον μία από τις παραπάνω αγωγές.

Inglês

concomitant stable doses of aminosalicylates, corticosteroids, and/ or immunomodulatory agents were permitted and 79% of patients continued to receive at least one of these medications.

Última atualização: 2012-04-11
Frequência de uso: 2
Qualidade:

Grego

Σε ασθενείς με ρευματοειδή αρθρίτιδα, ψωριασική αρθρίτιδα και νόσο του crohn, υπάρχουν ενδείξεις ότι η σύγχρονη χρήση μεθοτρεξάτης και άλλων ανοσοτροποποιητικών μειώνει το σχηματισμό αντισωμάτων κατά του infliximab και αυξάνει τις συγκεντρώσεις πλάσματος του infliximab.

Inglês

in rheumatoid arthritis, psoriatic arthritis and crohn's disease patients, there are indications that concomitant use of methotrexate and other immunomodulators reduces the formation of antibodies against infliximab and increases the plasma concentrations of infliximab.

Última atualização: 2011-10-23
Frequência de uso: 1
Qualidade:

Aviso: esta concordância pode estar incorreta.
Exclua-a, se este for o caso.

Grego

Ταυτόχρονη σταθερή χορήγηση δόσεων αµινοσαλικυλικών, κορτικοστεροειδών και/ή ανοσοτροποποιητικών παραγόντων επετράπησαν και το 79% των ασθενών συνέχισαν να λαµβάνουν τουλάχιστον µία από τις παραπάνω αγωγές.

Inglês

concomitant stable doses of aminosalicylates, corticosteroids, and/or immunomodulatory agents were permitted and 79% of patients continued to receive at least one of these medications.

Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:

Grego

Σε ασθενείς με ρευματοειδή αρθρίτιδα, ψωριασική αρθρίτιδα και νόσο του crohn, υπάρχουν ενδείξεις ότι η ταυτόχρονη χρήση μεθοτρεξάτης και άλλων ανοσοτροποποιητικών μειώνει το σχηματισμό αντισωμάτων κατά του infliximab και αυξάνει τις συγκεντρώσεις πλάσματος του infliximab.

Inglês

in rheumatoid arthritis, psoriatic arthritis and crohn's disease patients, there are indications that concomitant use of methotrexate and other immunomodulators reduces the formation of antibodies against infliximab and increases the plasma concentrations of infliximab.

Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:

Grego

Σε ασθενείς με ρευματοειδή αρθρίτιδα, ψωριασική αρθρίτιδα και νόσο του crohn, υπάρχουν ενδείξεις ότι η ταυτόχρονη χρήση μεθοτρεξάτης και άλλων ανοσοτροποποιητικών μειώνει τον σχηματισμό αντισωμάτων κατά του infliximab και αυξάνει τις συγκεντρώσεις πλάσματος του infliximab.

Inglês

in rheumatoid arthritis, psoriatic arthritis and crohn's disease patients, there are indications that concomitant use of methotrexate and other immunomodulators reduces the formation of antibodies against infliximab and increases the plasma concentrations of infliximab.

Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:

Consiga uma tradução melhor através
4,401,923,520 de colaborações humanas

Usuários estão solicitando auxílio neste momento:



Utilizamos cookies para aprimorar sua experiência. Se avançar no acesso a este site, você estará concordando com o uso dos nossos cookies. Saiba mais. OK